Kodiak Sciences Inc. Announces 2024 Annual Meeting of Stockholders

Ticker: KOD · Form: DEF 14A · Filed: Apr 23, 2024 · CIK: 1468748

Kodiak Sciences Inc. DEF 14A Filing Summary
FieldDetail
CompanyKodiak Sciences Inc. (KOD)
Form TypeDEF 14A
Filed DateApr 23, 2024
Risk Levellow
Pages15
Reading Time18 min
Sentimentneutral

Sentiment: neutral

Topics: Kodiak Sciences, Annual Meeting, Proxy Statement, Virtual Meeting, Stockholder Voting

TL;DR

<b>Kodiak Sciences Inc. is holding its 2024 Annual Meeting of Stockholders virtually on June 4, 2024, with April 5, 2024, as the record date.</b>

AI Summary

Kodiak Sciences Inc. (KOD) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. Kodiak Sciences Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 4, 2024, at 9:00 a.m. Pacific Time. Stockholders can attend, vote, and submit questions electronically via live webcast. The record date for determining stockholders entitled to vote is April 5, 2024. The company is incorporated in Delaware and its fiscal year ends on December 31. The filing is a Definitive Proxy Statement (DEF 14A) filed on April 23, 2024.

Why It Matters

For investors and stakeholders tracking Kodiak Sciences Inc., this filing contains several important signals. This proxy statement provides essential information for stockholders to participate in the annual meeting, including details on voting procedures and the business to be conducted. The virtual format allows for broader participation and electronic voting, emphasizing the importance of shareholder representation regardless of attendance.

Risk Assessment

Risk Level: low — Kodiak Sciences Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, containing standard disclosures and no immediate material financial or operational news.

Analyst Insight

Stockholders should review the proxy statement to understand the proposals and exercise their voting rights for the upcoming annual meeting.

Key Numbers

  • 2024 — Annual Meeting Year (2024 Annual Meeting of Stockholders)
  • June 4, 2024 — Annual Meeting Date (Date of the 2024 Annual Meeting of Stockholders)
  • 9:00 a.m. Pacific Time — Annual Meeting Time (Time of the 2024 Annual Meeting of Stockholders)
  • April 5, 2024 — Record Date (Record date for determining stockholders entitled to vote)
  • 2024-04-23 — Filing Date (Date the Definitive Proxy Statement was filed)

Key Players & Entities

  • Kodiak Sciences Inc. (company) — Registrant name and company name
  • Victor Perlroth, M.D. (person) — Chief Executive Officer and Chairman of the Board
  • June 4, 2024 (date) — Date of the Annual Meeting
  • April 5, 2024 (date) — Record date for the meeting
  • April 23, 2024 (date) — Filing date of the proxy statement
  • 1200 Page Mill Rd (address) — Company's business and mailing address
  • Palo Alto, CA 94304 (address) — Company's business and mailing address
  • DEF 14A (filing_type) — Form type of the filing

FAQ

When did Kodiak Sciences Inc. file this DEF 14A?

Kodiak Sciences Inc. filed this Proxy Statement (DEF 14A) with the SEC on April 23, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Kodiak Sciences Inc. (KOD).

Where can I read the original DEF 14A filing from Kodiak Sciences Inc.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Kodiak Sciences Inc..

What are the key takeaways from Kodiak Sciences Inc.'s DEF 14A?

Kodiak Sciences Inc. filed this DEF 14A on April 23, 2024. Key takeaways: Kodiak Sciences Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 4, 2024, at 9:00 a.m. Pacific Time.. Stockholders can attend, vote, and submit questions electronically via live webcast.. The record date for determining stockholders entitled to vote is April 5, 2024..

Is Kodiak Sciences Inc. a risky investment based on this filing?

Based on this DEF 14A, Kodiak Sciences Inc. presents a relatively low-risk profile. The filing is a routine proxy statement for an annual meeting, containing standard disclosures and no immediate material financial or operational news.

What should investors do after reading Kodiak Sciences Inc.'s DEF 14A?

Stockholders should review the proxy statement to understand the proposals and exercise their voting rights for the upcoming annual meeting. The overall sentiment from this filing is neutral.

Key Dates

  • 2024-06-04: 2024 Annual Meeting of Stockholders — Key date for shareholders to vote and participate in company governance.
  • 2024-04-05: Record Date — Determines which shareholders are eligible to vote at the annual meeting.
  • 2024-04-23: Filing Date — Date the Definitive Proxy Statement was publicly filed with the SEC.

Filing Stats: 4,455 words · 18 min read · ~15 pages · Grade level 14 · Accepted 2024-04-23 16:21:52

Filing Documents

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 32 2023 Summary Compensation Table 33 2023 Outstanding Equity Awards at Fiscal Year-End Table 34 Executive Employment Contracts and Change in Control Arrangements 35 Pay Versus Performance 39 PROPOSAL NO. 3 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 39 Fees Paid to the Independent Registered Public Accounting Firm 39 Auditor Independence 40 Audit Committee Policy on Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm 41 AUDIT COMMITTEE REPORT 42

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL 44 SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS 45 RELATED-PERSON TRANSACTIONS 46 OTHER MATTERS 47 QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING This proxy statement contains forward-looking financial trends affecting the financial condition of our business. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or managements good faith beliefs as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Forward-looking statements include all statements that are not historical facts. In some cases, you can identify forward-looking statements by terms such as may, might, will, objective, intend, should, could, can, would, expect, believe, anticipate, project, target, design, estimate, predict, potential, plan, hope or the negative of these terms, or similar expressions and comparable terminology intended to identify forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Forward-looking statements include, but are not limited to, statements about durability of prior study results, continued progression of our ABC Platform with duet and triplet programs, progress and timing of our ongoing Pha

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.